Drug Profile
Anti-interleukin-4 monoclonal antibody 11B11
Alternative Names: 11B11; Anti-interleukin-4 antibody 11B11Latest Information Update: 19 Nov 2003
Price :
$50
*
At a glance
- Originator Nonindustrial sources; University of Tokyo
- Class Monoclonal antibodies
- Mechanism of Action Interleukin 4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Graft-versus-host disease; Systemic lupus erythematosus
Most Recent Events
- 19 Nov 2003 Discontinued - Preclinical for Cancer in Japan (Intraperitoneal)
- 19 Nov 2003 Discontinued - Preclinical for Graft-versus-host disease in Germany (unspecified route)
- 19 Nov 2003 Discontinued - Preclinical for Graft-versus-host disease in Japan (unspecified route)